Recent Quotes (30 days)

You have no recent quotes
chg | %

Healthcare News

Showing stories 1 - 10 of about 70   
Is Johnson & Johnson a Buy?
Johnson & Johnson's (NYSE:JNJ) mission is to "help people everywhere live longer, healthier, happier lives." For decades, the healthcare titan has done just that, while also delivering tremendous returns to shareholders along the way.
Johnson & Johnson (JNJ) Closes 0.67% Up on the Day for January 15
How Does Johnson & Johnson (JNJ) Stack Up Right Now?  StockNewsJournal
How Financially Strong Is Pfizer Inc (NYSE:PFE)?
Investors seeking to preserve capital in a volatile environment might consider large-cap stocks such as Pfizer Inc (NYSE:PFE) a safer option.
Jarislowsky Fraser LTD Decreased Its Pfizer INC (PFE) Position by $5.82 ...  Frisco Fastball
Checking the Overall Picture for Pfizer Inc. (PFE)  StockNewsJournal
France fines Johnson & Johnson about $30 million over painkiller patch
French authorities fined Johnson & Johnson $29.62 million after it found the company had deliberately slowed market access to generic copies of Durogesic.
Johnson & Johnson fined 25 mln euros by French competition watchdog  Reuters
Pfizer Inc. Announces Expiration and Results of its Tender Offer for its 5.750 ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) (“Pfizer”) today announced the expiration and results of its previously announced (i) offer to purchase for cash (the “Tender Offer”) any and all of its outstanding €2,000,000,000 5.750 per cent.
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2018
NEW BRUNSWICK, N.J., Jan. 2, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2018 of $0.84 per share on the company's common stock.
Digging Up the Facts on Johnson & Johnson (JNJ)  StockNewsJournal
Johnson & Johnson (JNJ) Closes 0.66% Down on the Day for January 02
EXCLUSIVE: Johnson & Johnson Officially Debuts Digital Beauty Innovation Group
The health and skin-care company proves that its focus on beauty innovation is not just skin deep. By Adriana Lee on January 9, 2018.
After impressing at ASCO, Legend gains Johnson & Johnson as new CAR-T partner
The China biotech has come from relative obscurity to a $350 million Big Pharma deal in just a few months. (IQRemix/CC BY-SA 2.0).
Johnson & Johnson partners with Maharashtra government on health interventions
Maharashtra's mine workers who face an increased risk of tuberculosis will be part of awareness programmes on the illness, as part of a partnership that the Maharashtra Government recently formalized with Johnson & Johnson.
Johnson & Johnson Innovation Champions Leading Edge Science with 15 New ...
NEW BRUNSWICK, N.J., Jan. 5, 2018 /PRNewswire/ -- Johnson & Johnson Innovation LLC today announced more than a dozen new collaborations to drive the development of novel solutions to impact healthcare.
Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce an agreement with Pfizer Inc. (NYSE: PFE) to license the Distributed Bio ...